Dr. Yousif Abubakr, MD

Dr. Abubakr practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Abubakr's NPI, 1023013497, was assigned on June 14, 2005. Dr. Abubakr graduated from University of Khartoum Faculty of Medicine in 1986. Dr. Abubakr holds Florida license ME 70677.

Dr. Abubakr's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

Dr. Abubakr's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Abubakr is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Abubakr to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abubakr practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Abubakr's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abubakr is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Abubakr's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Abubakr treats.

CMS data shows 110,228 Medicare services from Dr. Abubakr across 44 procedure codes in 2024, for 946 Medicare patients. Medicare paid $915,054 for them.

CMS counts 946 Medicare patients who saw Dr. Abubakr in 2024. The largest group is 65 to 74, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abubakr's median patient age at 70, with 56% women.

In 2024, Dr. Abubakr wrote 1,040 Medicare Part D claims for 148 patients. 74% of them were for generic drugs. CMS names the drug for 841 of them, across 35 drugs with 11 or more claims each, at $2,103,056 in total drug cost. In 2023, CMS named 570 claims across 22 drugs.

Dr. Abubakr accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Abubakr in 2008. The most frequent topics are Tumor Cells, Cultured, Antibodies, Monoclonal and Antibodies, Monoclonal, Humanized. Dr. Abubakr has published most often in J Clin Oncol. Dr. Abubakr's most frequent co-authors are Ayad M. Al-Katib, MD, Louis Fehrenbacher, MD and Howard A. Burris, MD.

CMS Open Payments shows 79 general payments to Dr. Abubakr from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Inari Medical, Inc. paid the most, $363.

Dmand AI lists 2 awards for Dr. Abubakr, most recently CMS Stage 1 EHR in 2013.

Dr. Abubakr graduated from University of Khartoum Faculty of Medicine in 1986. Dr. Abubakr is a member of ASCO.

Dr. Abubakr is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.